Lot-to-Lot Bridging in Biomarker StudiesBy Dr. Afshin Safavi
Immunogenicity Trends: What’s Leading the Field Today?By Dr. Arno Kromminga
PK, Immunogenicity, and Biomarkers in Difficult MatricesBy Kathryn Lindley and Dr. Jennifer Zemo